The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 3M CO | COM | 88579Y101 | 15,828,333 | 144,789 | SH | SOLE | 144,789 | 0 | 0 | |||
| ARBUTUS BIOPHARMA CORP | COM | 03879J100 | 22,604,818 | 9,041,927 | SH | SOLE | 9,041,927 | 0 | 0 | |||
| ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 22,981,499 | 7,686,120 | SH | SOLE | 7,686,120 | 0 | 0 | |||
| ESPERION THERAPEUTICS INC NE | NOTE 4.000%11/1 | 29664WAB1 | 10,041,094 | 17,275,000 | PRN | SOLE | 17,275,000 | 0 | 0 | |||
| HERTZ GLOBAL HLDGS INC | *W EXP 06/30/205 | 42806J148 | 92,289 | 16,841 | SH | SOLE | 16,841 | 0 | 0 | |||
| HERTZ GLOBAL HLDGS INC | COM NEW | 42806J700 | 801,983 | 77,188 | SH | SOLE | 77,188 | 0 | 0 | |||
| IMMUNOVANT INC | COM | 45258J102 | 8,373,422 | 198,752 | SH | SOLE | 198,752 | 0 | 0 | |||
| IMMUNOVANT INC | COM | 45258J102 | 3,648,458 | 86,600 | SH | Call | SOLE | 86,600 | 0 | 0 | ||
| INDIVIOR PLC | ORD | G4766E116 | 210,892,336 | 13,810,893 | SH | SOLE | 13,810,893 | 0 | 0 | |||
| META PLATFORMS INC | CL A | 30303M102 | 9,264,903 | 26,175 | SH | SOLE | 26,175 | 0 | 0 | |||
| ODYSSEY MARINE EXPL INC | COM NEW | 676118201 | 6,379,214 | 1,371,874 | SH | SOLE | 1,371,874 | 0 | 0 | |||
| ROIVANT SCIENCES LTD | SHS | G76279101 | 95,547,344 | 8,508,223 | SH | SOLE | 8,508,223 | 0 | 0 | |||
| SONOS INC | COM | 83570H108 | 3,080,606 | 179,732 | SH | SOLE | 179,732 | 0 | 0 | |||